MDA-MB-435 and M14 cell lines: Identical but not M14 melanoma?

Cancer Research

Volumn 69, Issue 13, 2009, Pages 5292-5293

  Chambers, Ann F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL LINE; CELL LINEAGE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA FINGERPRINTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; KARYOTYPE; M14 CELL LINE; MDA MB 435 CELL LINE; MELANOMA CELL; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA, COMPLEMENTARY; FEMALE; GENETIC MARKERS; HISTOCOMPATIBILITY TESTING; HUMANS; MELANOMA; MILK, HUMAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 67650456890     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1528     Document Type: Review

References (23)

1. Cailleau R, Olive M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978;14:911-5.
2. Price JE. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 1996;39:93-102.
3. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990;50:717-21.
4. Price JE, Zhang RD. Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev 1990;8:285-97.
5. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 2007;104: 13-9.
6. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-35.
7. Suzuki M, Mose ES, Montel V, Tarin D. Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastasis potency. Am J Pathol 2006; 169:673-81.
8. Welch DR. Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 1997;15: 272-306.
9. Sellappan S, Grijalva R, Zhou X, et al. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 2004;64:3479-85.
10. Howlett AR, Petersen OW, Steeg PS, Bissell MJ. A novel function for the nm23-1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 1994;86:1838-44.
11. Ellison G, Klinowska T, Westwood RF, Docter E, French T, Fox JC. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 2002;55: 294-9.
12. Bignold LP. Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability. Int J Exp Pathol 2005;86:67-79.
13. Padmore RF, Lara JF, Ackerman DJ, et al. Primary combined malignant melanoma and ductal carcinoma of the breast. A report of two cases. Cancer 1996;78: 2515-25.
14. Nobukawa B, Fujii H, Hirai S, et al. Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses. Am J Surg Pathol 1999;23:1280-7.
15. Yen H, Florentine B, Kelly LK, Bu X, Crawford J, Martin SE. Fine-needle aspiration of a metaplastic breast carcinoma with extensive melanocytic differentiation: a case report. Diagn Cytopathol 2000;23:46-50.
16. Ruffolo EF, Koerner FC, Maluf HM. Metaplastic carcinoma of the breast with melanocytic differentiation. Mod Pathol 1997;10:592-6.
17. Bachmeier BE, Nerlich AG, Mirisola V, Jochum M, Pfeffer U. Lineage infidelity and expression of melanocytic markers in human breast cancer. Int J Oncol 2008; 33:1011-5.
18. Rae JM, Ramus SJ, Waltham M, et al. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis 2004;21:543-52.
19. Sulit HL, Golub SH, Irie RF, Gupta RK, Grooms GA, Morton DL. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects. Int J Cancer 1976;17:461-8.
20. Chee DO, Boddie AW, Roth JA, Holmes EC, Morton DL. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium. Cancer Res 1976;36:1503-9.
21. Wong JH, Aguero B, Gupta RK, Morton DL. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients. Cancer Immunol Immunother 1988;27:142-6.
22. Tuna M, Knuutila S, Mills GB. Uniparental disomy in cancer. Trends Mol Med 2009;15:120-8.
23. Richardson AL, Wang ZC, De Nicolo A, et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006;9:121-32.